Fortress Biotech, Inc. (FBIOP) Operating income 2016–2025
Fortress Biotech, Inc. (FBIOP) annual operating income history from SEC filings — each fiscal year as reported.
-$70.2MFY2025 · since FY2016: -$65.7M → -$70.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$70.2M | +36.4% |
| FY2024 | -$110.4M | +22.5% |
| FY2023 | -$142.3M | +30.1% |
| FY2022 | -$203.6M | -8.0% |
| FY2021 | -$188.5M | -100.0% |
| FY2020 | -$94.3M | +14.9% |
| FY2019 | -$110.8M | +7.6% |
| FY2018 | -$120.0M | -33.6% |
| FY2017 | -$89.8M | -36.7% |
| FY2016 | -$65.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice